3126 - 3150 of 9140 Results
Title
Year
- L-Dopa response, choreic dyskinesia, and dystonia in Perry syndrome2022RESTRICTEDTitle: L-Dopa response, choreic dyskinesia, and dystonia in Perry syndromeJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 100Issue #:Start Page: 19End Page: 23Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.05.023Citation Count: 8
- Pallidal neuronal activity in multiple system atrophy type P and Parkinson's disease2022RESTRICTEDTitle: Pallidal neuronal activity in multiple system atrophy type P and Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 15End Page: 17Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.007Citation Count: 1
-
OPENTitle: Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 75End Page: 89Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.013Best OA location URL: http://www.prd-journal.com/article/S1353802022002048/pdfCitation Count: 23
- The effect of limb selection methods on gait analysis in Parkinson's disease2022RESTRICTEDTitle: The effect of limb selection methods on gait analysis in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 104Issue #:Start Page: 81End Page: 84Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.013Citation Count: 2
- Serial olfactory testing for the diagnosis of prodromal Parkinson's disease in the PARS study2022RESTRICTEDTitle: Serial olfactory testing for the diagnosis of prodromal Parkinson's disease in the PARS studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 104Issue #:Start Page: 15End Page: 20Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.09.007Citation Count: 11
-
OPENTitle: Characterization and diagnostic potential of R2* in early-stage progressive supranuclear palsy variantsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 43End Page: 48Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.021Best OA location URL: http://www.prd-journal.com/article/S1353802022002176/pdfCitation Count: 11
- Tracer development for PET imaging of proteinopathies2022RESTRICTEDTitle: Tracer development for PET imaging of proteinopathiesJournal Name: Nuclear Medicine and BiologyPublisher: Elsevier BVVol: 114-115Issue #:Start Page: 137End Page: 147Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nucmedbio.2022.04.001Citation Count: 0
- Deciphering the molecular mechanism and crosstalk between Parkinson's disease and breast cancer through multi-omics and drug repurposing approach2022RESTRICTEDTitle: Deciphering the molecular mechanism and crosstalk between Parkinson's disease and breast cancer through multi-omics and drug repurposing approachJournal Name: NeuropeptidesPublisher: Elsevier BVVol: 96Issue #:Start Page: 102283End Page: 102283Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.npep.2022.102283Citation Count: 11
-
OPENTitle: Duration of benefit per Dose: Carbidopa-Levodopa immediate release vs. extended release capsules (Rytary®)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 82Issue #:Start Page: 133End Page: 137Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.002Best OA location URL: http://www.prd-journal.com/article/S1353802020309007/pdfCitation Count: 7
-
OPENTitle: Long-term safety and efficacy of apomorphine infusion in Parkinson's disease patients with persistent motor fluctuations: Results of the open-label phase of the TOLEDO studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 83Issue #:Start Page: 79End Page: 85Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.12.024Best OA location URL: http://www.prd-journal.com/article/S135380202100016X/pdfCitation Count: 84
- Author response to comment on “The association between pain and impulse control behaviours in Parkinson's disease”2021RESTRICTEDTitle: Author response to comment on “The association between pain and impulse control behaviours in Parkinson's disease”Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 83Issue #:Start Page: 128End Page: 129Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.01.011Citation Count: 0
- White matter hyperintensities mediate the impact of amyloid ß on future freezing of gait in Parkinson's disease2021RESTRICTEDTitle: White matter hyperintensities mediate the impact of amyloid ß on future freezing of gait in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 85Issue #:Start Page: 95End Page: 101Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.02.031Citation Count: 20
-
OPENTitle: Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI databaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 86Issue #:Start Page: 34End Page: 37Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.03.007Best OA location URL: https://repositorio.uca.edu.ar/handle/123456789/11625Citation Count: 21
- Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson's disease2021RESTRICTEDTitle: Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson's diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 186Issue #:Start Page: 108465End Page: 108465Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108465Citation Count: 19
- Special Issue on new therapeutic approaches to Parkinson disease2022RESTRICTEDTitle: Special Issue on new therapeutic approaches to Parkinson diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 208Issue #:Start Page: 108998End Page: 108998Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.108998Citation Count: 5
- Preserved motor memory in Parkinson's disease2022RESTRICTEDTitle: Preserved motor memory in Parkinson's diseaseJournal Name: NeuropsychologiaPublisher: Elsevier BVVol: 167Issue #:Start Page: 108161End Page: 108161Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropsychologia.2022.108161Citation Count: 15
-
OPENTitle: Removal of proteinase K resistant αSyn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse modelJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 218Issue #:Start Page: 109213End Page: 109213Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.109213Best OA location URL: https://doi.org/10.1016/j.neuropharm.2022.109213Citation Count: 11
- Quantitative Cellular Changes in the Thalamus of Patients with Multiple System Atrophy2021RESTRICTEDTitle: Quantitative Cellular Changes in the Thalamus of Patients with Multiple System AtrophyJournal Name: NeurosciencePublisher: Elsevier BVVol: 459Issue #:Start Page: 142End Page: 152Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2021.02.003Citation Count: 5
-
OPENTitle: Analysis of voice as an assisting tool for detection of Parkinson's disease and its subsequent clinical interpretationJournal Name: Biomedical Signal Processing and ControlPublisher: Elsevier BVVol: 66Issue #:Start Page: 102415End Page: 102415Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.bspc.2021.102415Best OA location URL: https://doi.org/10.1016/j.bspc.2021.102415Citation Count: 65
-
OPENTitle: Pharmacological inhibition of AIMP2 aggregation attenuates α-synuclein aggregation and toxicity in Parkinson’s diseaseJournal Name: Biomedicine & PharmacotherapyPublisher: Elsevier BVVol: 156Issue #:Start Page: 113908End Page: 113908Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.biopha.2022.113908Best OA location URL: https://doi.org/10.1016/j.biopha.2022.113908Citation Count: 7
- A conversation with Judith Campisi: Leader in the field of aging research2021OPENTitle: A conversation with Judith Campisi: Leader in the field of aging researchJournal Name: Ageing Research ReviewsPublisher: Elsevier BVVol: 69Issue #:Start Page: 101366End Page: 101366Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.arr.2021.101366Citation Count: 2
-
OPENTitle: Data imputation and compression for Parkinson's disease clinical questionnairesJournal Name: Artificial Intelligence in MedicinePublisher: Elsevier BVVol: 114Issue #:Start Page: 102051End Page: 102051Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.artmed.2021.102051Best OA location URL: https://hal.science/hal-02570967/documentCitation Count: 30
-
OPENTitle: Subtle anomaly detection: Application to brain MRI analysis of de novo Parkinsonian patientsJournal Name: Artificial Intelligence in MedicinePublisher: Elsevier BVVol: 125Issue #:Start Page: 102251End Page: 102251Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.artmed.2022.102251Best OA location URL: https://doi.org/10.1016/j.artmed.2022.102251Citation Count: 15
-
OPENTitle: Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson’s disease and cognitionJournal Name: Brain, Behavior, and ImmunityPublisher: Elsevier BVVol: 101Issue #:Start Page: 182End Page: 193Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.bbi.2022.01.005Best OA location URL: https://doi.org/10.1016/j.bbi.2022.01.005Citation Count: 56
- Evaluation of the effects of the mGlu2/3 antagonist LY341495 on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset2022RESTRICTEDTitle: Evaluation of the effects of the mGlu2/3 antagonist LY341495 on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmosetJournal Name: Pharmacological ReportsPublisher: Springer Science and Business Media LLCVol: 74Issue #: 4Start Page: 614End Page: 625Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s43440-022-00378-9Citation Count: 5